InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Richard E Lowenthal, PRESIDENT AND CEO, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 31 open-market SEC Form 4 transactions: 0 purchases worth $0 and 31 sales worth $11.8M, reported from Feb 26, 24 to Aug 21, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $14.49 | $725K |
| Dec 17, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $11.67 | $584K |
| Dec 10, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $13.16 | $658K |
| Nov 19, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $13.95 | $698K |
| Nov 12, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 45.1K | $17.64 | $756K |
| Oct 15, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $15.25 | $744K |
| Oct 8, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $13.83 | $692K |
| Sep 17, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $12.93 | $647K |
| Sep 10, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $11.50 | $575K |
| Aug 20, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 36.2K | $16.26 | $535K |
| Aug 13, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 35.4K | $12.77 | $452K |
| Jul 16, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $11.40 | $570K |
| Jul 9, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $9.62 | $481K |
| Jun 12, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 48.0K | $9.15 | $439K |
| Jun 11, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 2.2K | $9.00 | $19K |
| May 16, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 44.7K | $9.06 | $405K |
| May 15, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 2.8K | $9.05 | $25K |
| May 14, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 2.9K | $9.01 | $26K |
| May 7, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $9.34 | $467K |
| Apr 16, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $9.28 | $464K |
| Apr 9, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $9.28 | $464K |
| Mar 25, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 47.6K | $9.12 | $434K |
| Mar 22, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 1.3K | $9.03 | $12K |
| Mar 21, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 372 | $9.00 | $3K |
| Mar 19, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 976 | $9.04 | $9K |
| Mar 15, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 48.5K | $9.14 | $443K |
| Mar 14, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 239 | $9.00 | $2K |
| Mar 13, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 1.5K | $9.00 | $14K |
| Feb 29, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 2.0K | $9.02 | $18K |
| Feb 28, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 49.0K | $9.02 | $442K |
| Feb 26, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 500 | $9.01 | $5K |